mRNA新冠疫苗接种后急性心肌炎病例分析
该研究基于杜克大学医学中心的前瞻性心脏磁共振注册登记,在2021年2月1日至4月30日期间识别出7例急性心肌炎患者,其中4例在接种第二剂mRNA新冠疫苗后5天内发生。4例患者均表现为严重胸痛、心肌损伤标志物升高并住院,心脏磁共振表现符合心肌炎。作者提示需进一步研究新冠疫苗接种与心肌炎的关联。
要点
- 2021年2-4月共识别7例急性心肌炎,其中4例在mRNA疫苗接种后5天内发生。
- 4例接种相关心肌炎中3例为年轻男性(23-36岁),1例为70岁女性。
- 所有4例均表现为严重胸痛、心肌损伤标志物升高并住院,磁共振符合心肌炎。
核心结论
- 7例急性心肌炎患者中4例有近期mRNA新冠疫苗接种史,但需进一步研究确定关联。
研究设计与样本
- 前瞻性结局注册登记,纳入杜克大学医学中心因心血管磁共振转诊的患者。
- 检索注册数据库:2017至2021年每年2月1日至4月30日期间的急性心肌炎患者,以及过去20年所有可能的疫苗相关心肌炎患者。
- 对可能疫苗相关心肌炎患者,补充电子健康记录和电话访谈数据。
主要发现
- 2021年2月1日至4月30日期间共识别7例急性心肌炎患者,其中4例发生在新冠疫苗接种后5天内。
- 4例中3例为年轻男性(年龄23-36岁),1例为70岁女性。
- 4例均接种了第二剂mRNA疫苗(2例mRNA-1273 Moderna,2例BNT162b2 Pfizer)。
- 4例均表现为严重胸痛、有心肌损伤的生物标志物证据并住院。
- 新冠和呼吸道病毒检测未提供其他解释;心脏磁共振显示区域功能障碍、晚期钆增强及native T1和T2升高,符合心肌炎。
临床怎么用
- 接种mRNA新冠疫苗后出现严重胸痛和心肌损伤标志物升高的患者,应考虑急性心肌炎并完善心脏磁共振评估。
局限性
- 样本量小,仅为注册登记中的观察性描述,无法确定新冠疫苗接种与心肌炎的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Vaccine-associated myocarditis is an unusual entity that has been described for the smallpox vaccine, but only anecdotal case reports have been described for other vaccines. Whether COVID-19 vaccination may be linked to the occurrence of myocarditis is unknown. OBJECTIVE: To describe a group of 7 patients with acute myocarditis over 3 months, 4 of whom had recent messenger RNA (mRNA) COVID-19 vaccination. DESIGN, SETTING, AND PARTICIPANTS: All patients referred for cardiovascular magnetic resonance imaging at Duke University Medical Center were asked to participate in a prospective outcomes registry. Two searches of the registry database were performed: first, to identify patients with acute myocarditis for the 3-month period between February 1 and April 30 for 2017 through 2021, and second, to identify all patients with possible vaccine-associated myocarditis for the past 20 years. Once patients with possible vaccine-associated myocarditis were identified, data available in the registry were supplemented by additional data collection from the electronic health record and a telephone interview. EXPOSURES: mRNA COVID-19 vaccine. MAIN OUTCOMES AND MEASURES: Occurrence of acute myocarditis by cardiovascular magnetic resonance imaging. RESULTS: In the 3-month period between February 1 and April 30, 2021, 7 patients with acute myocarditis were identified, of which 4 occurred within 5 days of COVID-19 vaccination. Three were younger male individuals (age, 23-36 years) and 1 was a 70-year-old female individual. All 4 had received the second dose of an mRNA vaccine (2 received mRNA-1273 [Moderna], and 2 received BNT162b2 [Pfizer]). All presented with severe chest pain, had biomarker evidence of myocardial injury, and were hospitalized. Coincident testing for COVID-19 and respiratory viruses provided no alternative explanation. Cardiac magnetic resonance imaging findings were typical for myocarditis, including regional dysfunction, late gadolinium enhancement, and elevated native T1 and T2. CONCLUSIONS AND RELEVANCE: In this study, magnetic resonance imaging findings were found to be consistent with acute myocarditis in 7 patients; 4 of whom had preceding COVID-19 vaccination. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.
引用
- Kim HW, Jenista ER, Wendell DC, et al. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021. PMID: 34185046. doi:10.1001/jamacardio.2021.2828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。